Cardiac amyloidosis in non-transplant cardiac surgery
- PMID: 33993535
- DOI: 10.1111/jocs.15629
Cardiac amyloidosis in non-transplant cardiac surgery
Abstract
Cardiac amyloidosis is a rare infiltrative cardiomyopathy that portends a poor prognosis. There is a growing recognition of co-existent aortic valve stenosis and transthyretin cardiac amyloidosis, with some studies suggesting that dual pathology may be associated increased risk of complication and mortality during surgical intervention. This review aims to evaluate the available literature on non-transplant cardiac surgical interventions in patients with cardiac amyloidosis, with particular focus on diagnosis, high surgical risk and areas of uncertainty that require further research.
Keywords: cardiovascular pathology; clinical review; coronary arterydisease; transplant; valve repair/replacement.
© 2021 Wiley Periodicals LLC.
References
REFERENCES
-
- Virchow R. Archiv fur pathologische anatomie and physiologie und fur klinischemedicin. Berlin. 1854;6:354-368.
-
- Guvenc I. Localized amyloidosis of the head and neck. Amyloidosis. 2011:2150-3262.
-
- Gilstrap L , Dominici F , Wang Y , et al. Epidemiology of cardiac amyloidosis-associated heart failure hospitalizations among fee-for-service medicare beneficiaries in the united states. Circ Heart Fail. 2019;12(6):e005407.
-
- Rubin J , Maurer M. Cardiac amyloidosis: overlooked, underappreciated and treatable. Annu Rev Med. 2020;71:201-219.
-
- Tanskanen M , Perualinna T , Polvikoski T , et al. Senile systemic amyloidosis affects 25% of the very aged and associated with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study. Ann Med. 2008;40:232-239.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
